|
1
|
Human Proteinpedia enables sharing of human protein data.
|
Nat Biotechnol
|
2008
|
4.21
|
|
2
|
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer.
|
Int J Cancer
|
2007
|
1.53
|
|
3
|
Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas.
|
Mol Cell Proteomics
|
2002
|
1.15
|
|
4
|
Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
|
Mol Oncol
|
2009
|
1.07
|
|
5
|
bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.
|
Int J Cancer
|
2002
|
1.01
|
|
6
|
Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.
|
Mol Cell Proteomics
|
2005
|
1.00
|
|
7
|
Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition.
|
Mol Cell Proteomics
|
2004
|
1.00
|
|
8
|
Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.
|
Mol Cell Proteomics
|
2009
|
0.98
|
|
9
|
Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
|
Proteomics
|
2008
|
0.95
|
|
10
|
Study of therapy resistance in cancer cells with functional proteome analysis.
|
Clin Chem Lab Med
|
2002
|
0.94
|
|
11
|
Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.
|
Mol Cell Proteomics
|
2005
|
0.93
|
|
12
|
Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.
|
Mol Cell Proteomics
|
2012
|
0.91
|
|
13
|
Endoplasmic reticulum resident proteins of normal human dermal fibroblasts are the major targets for oxidative stress induced by hydrogen peroxide.
|
Biochem J
|
2002
|
0.89
|
|
14
|
A single lysis solution for the analysis of tissue samples by different proteomic technologies.
|
Mol Oncol
|
2008
|
0.88
|
|
15
|
A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences.
|
Mol Cell Proteomics
|
2008
|
0.84
|
|
16
|
Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.
|
Mol Oncol
|
2010
|
0.82
|
|
17
|
Protein profiling of the human epidermis from the elderly reveals up-regulation of a signature of interferon-gamma-induced polypeptides that includes manganese-superoxide dismutase and the p85beta subunit of phosphatidylinositol 3-kinase.
|
Mol Cell Proteomics
|
2003
|
0.81
|
|
18
|
Human proteomic databases: a powerful resource for functional genomics in health and disease.
|
Prog Biophys Mol Biol
|
2002
|
0.81
|
|
19
|
Gel-based proteomics: what does MCP expect?
|
Mol Cell Proteomics
|
2004
|
0.77
|
|
20
|
Clinical proteomics.
|
Mol Cell Proteomics
|
2008
|
0.77
|
|
21
|
'Tackling cancer in the EU: the role of innovation'.
|
Mol Oncol
|
2008
|
0.76
|
|
22
|
Proteomic strategies in bladder cancer: From tissue to fluid and back.
|
Proteomics Clin Appl
|
2008
|
0.76
|
|
23
|
The Human Proteome Organization: a mission to advance proteome knowledge.
|
Mol Cell Proteomics
|
2002
|
0.76
|
|
24
|
Strong support from the scientific community to the idea of establishing a European Research Council within the Life Sciences.
|
FEBS Lett
|
2003
|
0.75
|
|
25
|
A European Research Council for all sciences: a dream that may come true.
|
FEBS Lett
|
2003
|
0.75
|
|
26
|
Promoting basic research in Europe.
|
FEBS Lett
|
2004
|
0.75
|
|
27
|
The European Union Sixth Framework Programme (FP6): where we stand and what are the implications of the consultation process.
|
FEBS Lett
|
2002
|
0.75
|
|
28
|
Molecular Oncology. Editorial.
|
Mol Oncol
|
2013
|
0.75
|
|
29
|
[Pathogenesis of breast cancer].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
30
|
A role for Federation of European Biochemical Societies (FEBS) in the European Research Area (ERA).
|
FEBS Lett
|
2002
|
0.75
|
|
31
|
The European Research Council: the 'Mayor Group' report and the Commission's views on basic research and its impact.
|
FEBS Lett
|
2004
|
0.75
|
|
32
|
Molecular Oncology journal has moved to open access.
|
Mol Oncol
|
2017
|
0.75
|